Literature DB >> 6264107

Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents.

V Rotter, M A Boss, D Baltimore.   

Abstract

Abelson murine leukemia virus (A-MuLV)-transformed cells, simian virus 40 (SV40)-transformed cells, and chemically transformed cells all have increased levels of a 50,000-molecular-weight host cell protein. The protein was detected with sera raised to the A-MuLV-transformed and chemically transformed cells and was tightly bound to T-antigen in extracts of SV40-transformed cells. Partial protease digests showed that the proteins from all three sources were indistinguishable. The three proteins were phosphorylated in cells, and the linkage of phosphate to the A-MuLV-associated P50 was to a serine residue. By immunofluorescence methods, P50-related protein was found on the surface of both normal lymphoid cells and A-MuLV-transformed lymphoid cells, but cell fractionation showed that the majority of P50 was free in the cytoplasm of the transformed cells. Immunofluorescence also showed that P50 was found in granules in the cytoplasm of both untransformed and SV40-transformed fibroblasts. Other cells gave indistinct patterns. Cocapping experiments showed that the A-MuLV-specified P120 protein is weakly associated with the surface P50-related protein of lymphoid cells, but no association of P120 and P50 could be demonstrated by immunoprecipitation methods. Although a monoclonal antiserum to P50 was used in many of these studies, the identity of the bulk P50 protein with the molecules that are reactive at the cell surface requires further study.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264107      PMCID: PMC171156     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Basis for the acquisition of malignant potential by mouse cells cultivated in vitro.

Authors:  S A Aaronson; G J Todaro
Journal:  Science       Date:  1968-11-29       Impact factor: 47.728

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit.

Authors:  J Luka; H Jörnvall; G Klein
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

4.  Expression of early genes of origin-defective mutants of simian virus 40.

Authors:  Y Gluzman; J F Sambrook; R J Frisque
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  A common transformation-related protein in murine sarcomas and leukemias.

Authors:  G Jay; A B DeLeo; E Appella; G C Dubois; L W Law; G Khoury; L J Old
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

7.  Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells.

Authors:  F McCormick; E Harlow
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

8.  Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.

Authors:  V Rotter; O N Witte; R Coffman; D Baltimore
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.

Authors:  E G Gurney; R O Harrison; J Fenno
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

10.  Monospecificity of bone marrow-derived lymphocytes.

Authors:  M C Raff; M Feldmann; S De Petris
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

View more
  41 in total

1.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

2.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.

Authors:  G G Hicks; S E Egan; A H Greenberg; M Mowat
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

4.  Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.

Authors:  D Wolf; N Harris; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

5.  Differential transformation of C3H10T1/2 cells by v-mos: sequential expression of transformation parameters.

Authors:  F A van der Hoorn; V Müller
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

6.  Immunologically distinct p53 molecules generated by alternative splicing.

Authors:  N Arai; D Nomura; K Yokota; D Wolf; E Brill; O Shohat; V Rotter
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

7.  Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.

Authors:  E Harlow; N M Williamson; R Ralston; D M Helfman; T E Adams
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

8.  Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA.

Authors:  L Sherman; N Dafni; J Lieman-Hurwitz; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts.

Authors:  M L Gope; M Chun; R Gope
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

10.  Inhibition of viral and cellular promoters by human wild-type p53.

Authors:  M A Subler; D W Martin; S Deb
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.